An official website of the United States government
Home
Name
Cladribine
Alternate Names
2-Chlorodeoxyadenosine
Chlorodeoxyadenosine
CldAdo
Leustatin
RWJ 26251
RWJ-26251
RWJ26251
Abbreviations
2CdA
Category
Chemotherapy
Subcategory
Antimetabolite
purine analogs
NSC Number
105014
Primary Site
Leukemia
Leukemic reticuloendotheliosis
Histology
None
Remarks
FDA approved for hairy cell leukemia treatment.
Currently in trials for other B cell leukemias and lymphomas, such as mantle cell lymphoma. Also used in the treatment of multiple sclerosis.
Currently in trials for other B cell leukemias and lymphomas, such as mantle cell lymphoma. Also used in the treatment of multiple sclerosis.
Coding
This drug should be coded
